Tag: edoxaban

Edoxaban emerges as alternative to dalteparin for cancer-associated VTE

A new analysis has identified patient populations with cancer-associated venous thromboembolism (VTE) who could benefit from treatment with oral anticoagulant edoxaban, taken once daily. Daiichi...

First patient enrolled in Daiichi Sankyo European edoxaban registry

The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...